Literature DB >> 33846436

Key biomarkers within the colorectal cancer related inflammatory microenvironment.

Valentin Calu1,2, Adriana Ionescu3, Loredana Stanca4, Ovidiu Ionut Geicu4,5, Florin Iordache4, Aurelia Magdalena Pisoschi4, Andreea Iren Serban6,7, Liviu Bilteanu4,8.   

Abstract

Therapeutic approaches focused on the inflammatory microenvironment are currently gaining more support, as biomolecules involved in the inflammatory colorectal cancer (CRC) tumor microenvironment are being explored. We analyzed tumor and paired normal tissue samples from CRC patients (n = 22) whom underwent tumor resection surgery. We assessed 39 inflammation-involved biomolecules (multiplex magnetic bead-based immunoassay), CEA and CA19-9 (ELISA assay) and the tissue expression levels of occludin and also pErkSTAT1 and STAT3 transcriptional factors (western blot). Tumor staging has been established by histopathological evaluation of HE stained tumor tissue sections. We report 32 biomarkers displaying statistically significant differences in tumor vs. control. Additionally, positive statistical biomarker correlations were found between MMP2-IL8 and BAFF-IL8 (Pearson correlation coefficients > 0.751), while APRIL-MMP2, APRIL-BAFF and APRIL-IL8 were negatively correlated (correlation coefficients < - 0.650). While APRIL, BAFF, IL8 and MMP2 did not modulate with tumor stage, they were inversely related to the immune infiltrate level and CD163 tissue expression. We conclude that the significantly decreased APRIL and increased BAFF, IL8 and MMP2 expression were tumor-specific and deserve consideration in the development of new treatments. Also, the positive correlation between Chitinase 3-like 1 and IL8 (0.57) or MMP2 (0.50) suggest a role in tumor growth and metastasis pathways.

Entities:  

Year:  2021        PMID: 33846436     DOI: 10.1038/s41598-021-86941-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  45 in total

Review 1.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

2.  Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities.

Authors:  G Nogueira-Costa; I Fernandes; R Gameiro; J Gramaça; A T Xavier; I Pina
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

Review 3.  Cytokines, inflammation and colon cancer.

Authors:  Lidija Klampfer
Journal:  Curr Cancer Drug Targets       Date:  2011-05       Impact factor: 3.428

4.  Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth.

Authors:  Florian M Corvinus; Carina Orth; Richard Moriggl; Svetlana A Tsareva; Stefan Wagner; Edith B Pfitzner; Daniela Baus; Roland Kaufmann; Lukas A Huber; Kurt Zatloukal; Hartmut Beug; Peter Ohlschläger; Alexander Schütz; Karl-Jürgen Halbhuber; Karlheinz Friedrich
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

Review 5.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 6.  Systematic review of blood diagnostic markers in colorectal cancer.

Authors:  Stella Nikolaou; Shengyang Qiu; Francesca Fiorentino; Shahnawaz Rasheed; Paris Tekkis; Christos Kontovounisios
Journal:  Tech Coloproctol       Date:  2018-07-18       Impact factor: 3.781

Review 7.  Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy.

Authors:  Daria S Chulpanova; Kristina V Kitaeva; Andrew R Green; Albert A Rizvanov; Valeriya V Solovyeva
Journal:  Front Cell Dev Biol       Date:  2020-06-03

8.  Immune Condition of Colorectal Cancer Patients Featured by Serum Chemokines and Gene Expressions of CD4+ Cells in Blood.

Authors:  Takuya Komura; Masaaki Yano; Akimitsu Miyake; Hisashi Takabatake; Masaki Miyazawa; Norihiko Ogawa; Akihiro Seki; Masao Honda; Takashi Wada; Shigeyuki Matsui; Shuichi Kaneko; Yoshio Sakai
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-11

Review 9.  Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer.

Authors:  Noomi Vainer; Christian Dehlendorff; Julia S Johansen
Journal:  Oncotarget       Date:  2018-07-03

10.  Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.

Authors:  Megha Bhardwaj; Korbinian Weigl; Kaja Tikk; Axel Benner; Petra Schrotz-King; Hermann Brenner
Journal:  Mol Oncol       Date:  2019-11-13       Impact factor: 6.603

View more
  6 in total

Review 1.  The role and therapeutic implication of endoplasmic reticulum stress in inflammatory cancer transformation.

Authors:  Yuan Li; Lu Lu; Guangtao Zhang; Guang Ji; Hanchen Xu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 2.  Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers.

Authors:  Lindsey Carlsen; Kelsey E Huntington; Wafik S El-Deiry
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

Review 3.  Biomarkers of Response and Resistance to Immunotherapy in Microsatellite Stable Colorectal Cancer: Toward a New Personalized Medicine.

Authors:  Nicolas Huyghe; Elena Benidovskaya; Philippe Stevens; Marc Van den Eynde
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

4.  Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers.

Authors:  Adriana Ionescu; Liviu Bilteanu; Ovidiu Ionut Geicu; Florin Iordache; Loredana Stanca; Aurelia Magdalena Pisoschi; Adrian Miron; Andreea Iren Serban; Valentin Calu
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

Review 5.  Biomarkers to Detect Early-Stage Colorectal Cancer.

Authors:  Jacqueline I Keenan; Frank A Frizelle
Journal:  Biomedicines       Date:  2022-01-25

6.  Binary MoS2 nanostructures as nanocarriers for amplification in multiplexed electrochemical immunosensing: simultaneous determination of B cell activation factor and proliferation-induced signal immunity-related cytokines.

Authors:  Beatriz Arévalo; Marina Blázquez-García; Alejandro Valverde; Verónica Serafín; Ana Montero-Calle; Guillermo Solís-Fernández; Rodrigo Barderas; Susana Campuzano; Paloma Yáñez-Sedeño; José M Pingarrón
Journal:  Mikrochim Acta       Date:  2022-03-14       Impact factor: 6.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.